Why is Alibaba stock sliding today?

Alibaba fell 4.8% to HK$90.4, near a 17-month low, and is now roughly 50% below its October 2025 peak of HK$186.2 as multiple headwinds hit sentiment. Anthropic accused Alibaba-linked operators of using nearly 25,000 fraudulent accounts in a large-scale Claude distillation attack, while Alibaba also sued the U.S. Department of Defense over its "Chinese Military Companies" designation. Weak 618 shopping festival results added to the pressure, with broader Hong Kong tech stocks already under heavy selling.

Analysis

The market is no longer pricing Alibaba as a normal China internet de-rating; it is treating the name as a regime-change story where legal, geopolitical, and product-integrity risks reinforce each other. That matters because the downside is not linear: once investors believe the company’s AI stack is both strategically constrained and potentially non-compliant with U.S. scrutiny, the multiple compresses faster than fundamentals can stabilize. In that setup, weak consumer demand is less the cause than the confirmation that there is no near-term earnings catalyst to offset the governance overhang.

The second-order winner is not a single direct competitor, but the broader basket of “cleaner” AI/platform exposures with less geopolitical friction. In China e-commerce, JD is comparatively better positioned if the market starts rotating from narrative-driven growth into balance-sheet and execution quality, though it is still exposed to the same demand softness. For semis and AI infrastructure, the key takeaway is that investors may increasingly discount Chinese AI innovation claims across the board, which can support non-China suppliers of compute, model tooling, and enterprise AI software outside the mainland ecosystem.

The most important catalyst path is time-based: over the next 1-4 weeks, headline risk can keep the stock under pressure regardless of valuation; over 3-6 months, the debate shifts to whether regulatory resolution or visible AI product monetization can restore confidence. The contrarian case is that the selloff may be over-discounting a worst-case outcome already, especially if the DoD process becomes procedural rather than punitive. But until the legal and reputational issues decouple, dip-buying is a falling-knife exercise, not a mean-reversion setup.

Technically, this kind of drawdown often forces incremental de-risking from momentum and passive holders, which can create forced supply even after bad news is absorbed. That suggests the highest-probability bounce is not a fundamental rerating, but a short-covering rally after a policy clarification or a stabilization in northbound flows. Without that, rallies should be sold into because the stock still lacks a credible catalyst to re-anchor expectations.

Key Decisions for Investors

• Short BABA on strength for a 1-4 week horizon; use rallies into headline relief as entry because the stock likely trades on legal/newsflow rather than fundamentals until a regulatory resolution is visible.
• Pair trade: long JD / short BABA for 1-3 months; JD has less direct AI-distillation and geopolitical overhang, so this isolates relative execution quality versus headline-driven multiple compression.
• Buy BABA put spreads 1-3 months out to express downside continuation while capping premium bleed; structure for a move to fresh lows if U.S. scrutiny escalates or northbound selling persists.
• If looking for a cleaner AI beta alternative, rotate exposure toward non-China AI beneficiaries rather than Chinese internet names; the market may increasingly penalize any mainland-linked AI monetization claims.
• Set a tactical cover level on BABA only if there is a formal de-escalation on the U.S. defense-list issue; absent that, treat any 5-10% bounce as tradable, not investable.